Live from the NIH registry
Studies recruiting near Paterson right now
Top 25 of 4,141 recruiting studies, sorted by proximity — each links to its official registry page
The Effects of Entrainment on Respiratory Stability and Cerebral Oxygenation in Preterm Infants
Prematurity
N/A
Interventional 120 participants sought
Mount Sinai Hospitals — New York, New York (16.1 mi)
· Sponsor: Icahn School of Medicine at Mount Sinai
FUS Etoposide for DMG
Diffuse Intrinsic Pontine Glioma, Diffuse Midline Glioma, H3 K27M-Mutant
Phase 1
Interventional 10 participants sought
Columbia University Irving Medical Center — New York, New York (16.1 mi)
· Sponsor: Columbia University
DBS for Depression
Treatment Resistant Depression
Phase 1
Interventional 20 participants sought
Zucker Hillside Hospital — Queens, New York (23.5 mi)
· Sponsor: Northwell Health
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
B Acute Lymphoblastic Leukemia
Phase 2
Interventional 222 participants sought
Saint Joseph's Regional Medical Center — Paterson, New Jersey (0.5 mi)
· Sponsor: National Cancer Institute (NCI)
Doxycycline Prophylaxis for Prevention of Sexually Transmitted Infections
Gonorrhea, Chlamydia
Phase 4
Interventional 760 participants sought
Harlem Prevention Center — New York, New York (16.1 mi)
· Sponsor: Westat
Acupuncture for People Experiencing Period Loss Due to Chemotherapy
Cancer, Period Problem
Phase 2
Interventional 60 participants sought
Memorial Sloan Kettering Bergen (All Protocol Activities) — Montvale, New Jersey (11.7 mi)
· Sponsor: Memorial Sloan Kettering Cancer Center
GATEWAY: Safety Evaluation of the MiniMed™ NMX8-AID System in Children and Adults Living With Diabetes
Type 1 Diabetes Mellitus, Type 2 Diabetes Mellitus
N/A
Interventional 400 participants sought
NYC Research Inc — Long Island City, New York (16.2 mi)
· Sponsor: Medtronic MiniMed, Inc.
Mobile CBT for Middle Aged and Older Adults
Anxiety Disorders and Symptoms, Depressive Symptoms
N/A
Interventional 60 participants sought
Weill Cornell Medicine — New York, New York (16.1 mi)
· Sponsor: Weill Medical College of Cornell University
E-cigarettes for Harm Reduction Among Smokers With Serious Mental Illness
Cigarette Smoking
N/A
Interventional 60 participants sought
NYU Langone Health — New York, New York (16.1 mi)
· Sponsor: NYU Langone Health
QuantifyHER: Quantitative Immunofluorescence and/or RT-qPCR for Measuring HER2 in HER2-low Metastatic Breast Cancer
HER2-positive Metastatic Breast Cancer
N/A
Observational 200 participants sought
Montefiore Einstein Medical Center — The Bronx, New York (16.1 mi)
· Sponsor: Abramson Cancer Center at Penn Medicine
A Clinical Study of Zilovertamab Vedotin (MK-2140) Plus Rituximab Plus Cyclophosphamide, Doxorubicin, and Prednisone (R-CHP) Versus Polatuzumab Vedotin Plus R-CHP in People With Diffuse Large B-cell Lymphoma (DLBCL) (MK-2140-011/waveLINE-011)
Lymphoma, Large B-Cell, Diffuse
Phase 2
Interventional 594 participants sought
Valley Health Systems - Ridgewood Campus ( Site 0125) — Paramus, New Jersey (5.0 mi)
· Sponsor: Merck Sharp & Dohme LLC
Effects of Hip Bump Manipulation Versus Sham Treatment in Healthy Adults
Assessment of Hip Strength, Range of Motion, EMG Activation, and Landing Mechanics in Healthy Subjects, Healthy Adult Subjects
N/A
Interventional 60 participants sought
Dominican University New York — Orangeburg, New York (14.4 mi)
· Sponsor: Dominican University New York
PENG vs Femoral Block for Hip Fracture Analgesia
Hip Fractures
N/A
Interventional 352 participants sought
Weill Cornell Medicine — Manhattan, New York (13.7 mi)
· Sponsor: Weill Medical College of Cornell University
A Study to Learn About the Study Medicine Elranatamab Alone and With Daratumumab in People With Multiple Myeloma Who Have Received Other Treatments
Multiple Myeloma
Phase 3
Interventional 893 participants sought
Memorial Sloan Kettering Cancer Center - David H. Koch Center for Cancer Care (74th Street). — New York, New York (16.1 mi)
· Sponsor: Pfizer
Community Health Workers United to Reduce Colorectal Cancer and Cardiovascular Disease Among People at Higher Risk
Colorectal Cancer
N/A
Interventional 880 participants sought
Columbia University Irving Medical Center — New York, New York (16.1 mi)
· Sponsor: Columbia University
A Study to Investigate the Safety and Efficacy of SAR446523 Injected Subcutaneously in Adult Participants With Relapsed/Refractory Myeloma
Plasma Cell Myeloma Refractory
Phase 1
Interventional 87 participants sought
Hackensack Meridian Health - Hackensack University Medical Center- Site Number : 8400001 — Hackensack, New Jersey (6.5 mi)
· Sponsor: Sanofi
DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer
Endometrial Cancer
Phase 3
Interventional 600 participants sought
Research Site — Hackensack, New Jersey (6.5 mi)
· Sponsor: AstraZeneca
MDMA-Assisted Therapy for Mental Healthcare Providers
Mental Wellbeing
Phase 1
Interventional 30 participants sought
The Parsons Research Center for Psychedelic Healing — New York, New York (16.1 mi)
· Sponsor: Rachel Yehuda
Study of Datopotamab Deruxtecan Plus Carboplatin or Cisplatin Versus Gemcitabine Plus Carboplatin or Cisplatin in Participants With Locally Advanced or Metastatic Urothelial Carcinoma
Urothelial Cancer, Bladder Cancer
Phase 2, Phase 3
Interventional 630 participants sought
Research Site — New York, New York (16.1 mi)
· Sponsor: Daiichi Sankyo
A Study to Evaluate the Efficacy of Cemsidomide + Dexamethasone in Participants With Relapsed/Refractory Multiple Myeloma
Multiple Myeloma, Relapsed/Refractory Multiple Myeloma
Phase 2
Interventional 100 participants sought
The Tisch Cancer Institute/Mount Sinai — New York, New York (16.1 mi)
· Sponsor: C4 Therapeutics, Inc.
A Study of Cemiplimab Plus Chemotherapy Versus Cemiplimab Plus Chemotherapy Plus Other Cancer Treatments for Adult Patients With Operable Non-Small Cell Lung Cancer (NSCLC)
Non-Small Cell Lung Cancer
Phase 2
Interventional 120 participants sought
Morristown Medical Center — Morristown, New Jersey (18.6 mi)
· Sponsor: Regeneron Pharmaceuticals
Studying the Presence of CFRD Complications With Thoughtful Recruitment (SPeCTRuM)
Cystic Fibrosis (CF), Cystic Fibrosis-related Diabetes
N/A
Observational 200 participants sought
Columbia University Cystic Fibrosis Program — New York, New York (16.1 mi)
· Sponsor: Jaeb Center for Health Research
HLA Demographics Study in Adults With Type 1 Diabetes
Diabetes Mellitus, Type I
N/A
Observational 200 participants sought
Icahn School of Medicine at Mount Sinai — New York, New York (16.1 mi)
· Sponsor: GentiBio, Inc
A Study of ERAS-0015 in Patients With Advanced or Metastatic Solid Tumors
Metastatic Solid Tumors
Phase 1
Interventional 600 participants sought
Memorial Sloan Kettering Cancer Center — New York, New York (16.1 mi)
· Sponsor: Erasca, Inc.
A Study of Buntanetap in Participants With PD
Parkinson's Disease (PD), Deep Brain Stimulation
Phase 2, Phase 3
Interventional 500 participants sought
Mount Sinai Hospital — New York, New York (16.1 mi)
· Sponsor: Annovis Bio Inc.